OXYGENTA PHARMACEUTICAL Financial Statement Analysis
|
||
|
The Revenues of OXYGENTA PHARMACEUTICAL have increased by 3.37% YoY .
The Earnings Per Share (EPS) of OXYGENTA PHARMACEUTICAL has decreased by Negative YoY. |
||
OXYGENTA PHARMACEUTICAL Last 5 Annual Financial Results
[BOM: 524636]
| Standalone | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹113 Cr | ₹109 Cr | ₹40 Cr | ₹31 Cr | ₹61 Cr |
| Expenses | ₹128 Cr | ₹119 Cr | ₹49 Cr | ₹38 Cr | ₹59 Cr |
| Operating Profit (Excl OI) | ₹-15 Cr | ₹-9.81 Cr | ₹-9.70 Cr | ₹-7.12 Cr | ₹1.48 Cr |
| Other Income | ₹0.29 Cr | ₹1.31 Cr | ₹0.04 Cr | ₹0.02 Cr | ₹0.01 Cr |
| Interest | ₹4.83 Cr | ₹2.23 Cr | ₹1.59 Cr | ₹1.49 Cr | ₹0.93 Cr |
| Depreciation | ₹2.32 Cr | ₹3.61 Cr | ₹2.66 Cr | ₹2.05 Cr | ₹1.59 Cr |
| Profit Before Tax | ₹-22 Cr | ₹-14 Cr | ₹-14 Cr | ₹-11 Cr | ₹-0.49 Cr |
| Profit After Tax | ₹-18 Cr | ₹-10 Cr | ₹-3.48 Cr | ₹-12 Cr | ₹-0.61 Cr |
| Earnings Per Share (Rs) | ₹-4.75 | ₹-2.78 | ₹-1.04 | ₹-8.15 | ₹-0.43 |
| PAT Margin (%) | -15.55 | -9.42 | -8.78 | -37.34 | -1.01 |
| ROE(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| ROCE(%) | -33.53 | -32.89 | -41.69 | -50.32 | 3.18 |
| Total Debt/Equity(x) | -2.57 | -2.43 | -2.77 | -1.47 | -1.51 |
Key Financials |
||
| Market Cap | : | ₹ 191.7 Cr |
| Revenue (TTM) | : | ₹ 134.8 Cr |
| Net Profit(TTM) | : | ₹ -13.6 Cr |
| EPS (TTM) | : | ₹ -3.7 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| OXYGENTA PHARMACEUTICAL | 3.5% | 10.8% | -52.9% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.3% | 3% | 12.3% |
| DIVIS LABORATORIES | 2.9% | 22.7% | 25.5% |
| TORRENT PHARMACEUTICALS | -2.7% | 2% | 33.9% |
| CIPLA | 0.1% | 3% | -7% |
| DR REDDYS LABORATORIES | 2.4% | -12.9% | -9.1% |
| MANKIND PHARMA | -1.6% | -2.3% | -4.8% |
| LUPIN | -0.9% | -2.7% | 20.3% |
| ZYDUS LIFESCIENCES | -1.8% | -3.7% | 11.7% |
OXYGENTA PHARMACEUTICAL Revenues
[BOM: 524636]
| Y-o-Y | 3.37 % |
| 5 Yr CAGR | 16.89 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹113 Cr | 3.37 | |
| Mar2025 | ₹109 Cr | 175.72 | |
| Mar2024 | ₹40 Cr | 27.93 | |
| Mar2023 | ₹31 Cr | -48.80 | |
| Mar2022 | ₹61 Cr | - | |
OXYGENTA PHARMACEUTICAL Operating Profit
[BOM: 524636]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-15 Cr | Negative | |
| Mar2025 | ₹-9.81 Cr | Negative | |
| Mar2024 | ₹-9.70 Cr | Negative | |
| Mar2023 | ₹-7.12 Cr | Negative | |
| Mar2022 | ₹1.48 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | -13.55% | Negative | |
| Mar2025 | -8.98% | Negative | |
| Mar2024 | -24.46% | Negative | |
| Mar2023 | -22.97% | Negative | |
| Mar2022 | 2.44% | - | |
OXYGENTA PHARMACEUTICAL Profit After Tax
[BOM: 524636]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹-18 Cr | Negative | |
| Mar2025 | ₹-10 Cr | Negative | |
| Mar2024 | ₹-3.48 Cr | Negative | |
| Mar2023 | ₹-12 Cr | Negative | |
| Mar2022 | ₹-0.61 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | -15.55 % | Negative | |
| Mar2025 | -9.42 % | Negative | |
| Mar2024 | -8.78 % | Negative | |
| Mar2023 | -37.34 % | Negative | |
| Mar2022 | -1.01 % | - | |
OXYGENTA PHARMACEUTICAL Earnings Per Share (EPS)
[BOM: 524636]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹-4.75 | Negative | |
| Mar2025 | ₹-2.78 | Negative | |
| Mar2024 | ₹-1.04 | Negative | |
| Mar2023 | ₹-8.15 | Negative | |
| Mar2022 | ₹-0.43 | - | |
OXYGENTA PHARMACEUTICAL Return on Capital Employed (ROCE)
[BOM: 524636]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | -33.53% | Negative | |
| Mar2025 | -32.89% | Negative | |
| Mar2024 | -41.69% | Negative | |
| Mar2023 | -50.32% | Negative | |
| Mar2022 | 3.18% | - | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Current Share Price | : | ₹51.8 |
| Current MarketCap | : | ₹ 191.7 Cr |
| Updated EOD on | : | Aug 06,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 3.5% |
10.8% |
-52.9% |
| SENSEX | 1.3% |
1% |
-2.9% |
OXYGENTA PHARMACEUTICAL related INDICES
You may also like the below Video Courses
FAQ about OXYGENTA PHARMACEUTICAL Financials
How the annual revenues of OXYGENTA PHARMACEUTICAL have changed ?
The Revenues of OXYGENTA PHARMACEUTICAL have increased by 3.37% YoY .
How the Earnings per Share (EPS) of OXYGENTA PHARMACEUTICAL have changed?
The Earnings Per Share (EPS) of OXYGENTA PHARMACEUTICAL has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs